Nicorandil Sandoz

Nicorandil, the active ingredient in Nicorandil Sandoz, is a nitrate vasodilator and ATP‑sensitive potassium channel opener presented as a tablet for oral use. It reduces cardiac preload and afterload, helping to relieve chest pain in adults with stable or chronic angina pectoris.

GNH USA supplies Nicorandil Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to this anti‑anginal medication across global markets.

Nicorandil is employed in the management of coronary artery disease‑related chest pain, acting as an anti‑anginal agent.

- Stable angina pectoris: reduces the frequency of angina attacks and improves exercise tolerance. - Chronic angina: alleviates persistent chest discomfort during daily activities. - Effort‑induced angina: decreases myocardial oxygen demand during physical exertion.

Nicorandil may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: mild to moderate throbbing pain, often transient. - Flushing: warm sensation and reddening of the skin. - Dizziness or light‑headedness, especially on standing. - Nausea or upset stomach. - Palpitations: awareness of heartbeats. - Mild hypotension: slight drop in blood pressure.

Serious or Rare Side Effects: - Severe hypotension: marked blood‑pressure fall requiring medical attention. - Tachycardia: rapid heart rate that may be symptomatic. - Bronchospasm: airway constriction, particularly in susceptible individuals. - Allergic reactions: rash, itching, or swelling of face and throat. - Gastro‑intestinal ulceration or perforation. - Stevens‑Johnson syndrome or toxic epidermal necrolysis.

When prescribing Nicorandil, clinicians should consider several safety aspects.

- Concomitant nitrate therapy: avoid additive vasodilation that can cause severe hypotension. - Use with PDE5 inhibitors (e.g., sildenafil): monitor for profound blood‑pressure reduction. - Renal impairment: adjust therapy and monitor renal function. - Hepatic impairment: use caution and consider dose modification. - Pregnancy and lactation: safety not established; weigh benefits against potential risks. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Nicorandil interacts with several drug classes that can modify its cardiovascular effects.

Major Interactions (Avoid): - Other nitrates (e.g., nitroglycerin): additive vasodilation leading to severe hypotension. - Phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil): risk of profound hypotension. - Potent antihypertensive agents: may excessively lower blood pressure.

Moderate Interactions (Monitor Closely): - Diuretics: increased risk of orthostatic hypotension. - Beta‑blockers: additive effect on heart‑rate control. - Calcium‑channel blockers: potential alteration of vascular tone and blood‑pressure response.